Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

BENITEC BIOPHARMA LIMITED

INVESTOR PRESENTATION - BENITEC BIOPHARMA LIMITED

ASX:BLT

BENITEC BIOPHARMA LIMITED

Health Care

Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011

Read more

Market Cap

8.35m

Price at Close

$0.026

4w avg. Volume

263.73k

4w avg. Turnover

$6.72k

Announcements
announcementt+2 movementdate
  • Removal from Official List

    Stock Exchange Announcement

  • -

    16 Apr 2020

-

16 Apr 2020
  • Implementation of Scheme of Arrangement

    Takeover Announcements · Market sensitive

  • -

    15 Apr 2020

-

15 Apr 2020
  • Benitec Inc Appoints Edward Smith to the Board of Directors

    Company Administration

  • -

    15 Apr 2020

-

15 Apr 2020
  • Voluntary delisting of ADSs and Warrants from Nasdaq

    Takeover Announcements

  • 0.00%

    03 Apr 2020

0.00%

03 Apr 2020
  • Position on FIRB approval

    Takeover Announcements · Market sensitive

  • 0.00%

    30 Mar 2020

0.00%

30 Mar 2020
  • Suspension from Official Quotation

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    30 Mar 2020

0.00%

30 Mar 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    30 Mar 2020

0.00%

30 Mar 2020
  • Pause in Trading

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    30 Mar 2020

0.00%

30 Mar 2020
  • Court approves re-domiciliation scheme

    Takeover Announcements · Market sensitive

  • 0.00%

    30 Mar 2020

0.00%

30 Mar 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • 0.00%

    29 Mar 2020

0.00%

29 Mar 2020
Market Data

Current Price

$0.026

52WK HIGH

$0.145

52WK LOW

$0.022

1YR RETURN

-80.74%

1YR RETURN VS. SECTOR

-153.46%

90 DAY RETURN

-31.58%

ASX RANK

1,519

/2,060

SECTOR RANK

41

/48

SHARES OUTSTANDING

321.29m
ASX:BLT

BENITEC BIOPHARMA LIMITED

Health Care

Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011

Read more

Market Cap

8.35m

Price at Close

$0.026

4w avg. Volume

263.73k

4w avg. Turnover

$6.72k

ASX:BLT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.